Compugen Financial Statements
Compugen Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Compugen Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.2 | 0.2 | 0.6 |
| Gross Profit ($ mil.) | -- | 0.2 | 0.5 |
| Operating Income ($ mil.) | (12.5) | (14.0) | (14.9) |
| Total Net Income ($ mil.) | (12.1) | (13.0) | (14.0) |
| Diluted EPS (Net Income) | (0.43) | (0.47) | (0.50) |
Compugen Quarterly Statements
| Quarter Ending Mar 01 | |
|---|---|
| Revenue ($ mil.) | 2.2 |
| Gross Profit ($ mil.) | -- |
| Operating Income ($ mil.) | -- |
| Total Net Income ($ mil.) | (3.6) |
| Diluted EPS (Net Income) | -- |
Compugen Stock Quote & Chart
12/02/08 12:10:03 EST •
NASDAQ •
0.55
•
 0.0000
•
0.0000 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Compugen Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 129.03 | 2.14 | 0.87 |
| Price/Earnings Ratio | -- | 9.26 | 9.48 |
| Price/Book Ratio | 1.34 | 1.57 | 0.84 |
| Price/Cash Flow Ratio | -- | 8.08 | 5.40 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Compugen Financial Ratios
Compugen Competitive Intelligence
| Amgen | Bayer AG | diaDexus | |
|---|---|---|---|
| Annual Sales ($ mil.) | 14,771.0 | 38,230.6 | 0.3 |
| Employees | 17,500 | 96,594 | 83 |
| Market Cap ($ mil.) | 61,665.6 | -- | -- |
Competitive Landscape
